GTEX-1B932
|
41-50
|
Female
|
GTEX-1B932-1426 |
Liver
|
PAXgene |
1
|
2 pieces; mild steatosis and congestion
|
Acceptable
|
|
GTEX-1B933
|
51-60
|
Female
|
GTEX-1B933-1226 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse macrovesicular steatosis involves ~70% of parenchyma
|
Acceptable
|
|
GTEX-1B98T
|
61-70
|
Male
|
GTEX-1B98T-1126 |
Liver
|
PAXgene |
1
|
2 pieces, moderate passive congestion
|
Acceptable
|
|
GTEX-1B996
|
61-70
|
Male
|
GTEX-1B996-1426 |
Liver
|
PAXgene |
1
|
2 pieces; marked congestion
|
Acceptable
|
|
GTEX-1BAJH
|
61-70
|
Male
|
GTEX-1BAJH-1526 |
Liver
|
PAXgene |
1
|
2 pieces; congestion
|
Acceptable
|
|
GTEX-1C64N
|
51-60
|
Male
|
GTEX-1C64N-1426 |
Liver
|
PAXgene |
1
|
2 pieces; congestion and mild steatosis, includes portion of capsule (not target)
|
Acceptable
|
|
GTEX-1C6VQ
|
51-60
|
Male
|
GTEX-1C6VQ-1626 |
Liver
|
PAXgene |
1
|
2 pieces; severe macrovesicular steatosis, centrilobular congestion, fibrosis
|
Acceptable
|
|
GTEX-1C6VR
|
61-70
|
Male
|
GTEX-1C6VR-1026 |
Liver
|
PAXgene |
1
|
2 pieces, trace macrovesicular steatosis (~10% of parenchyma)
|
Acceptable
|
|
GTEX-1C6VS
|
61-70
|
Male
|
GTEX-1C6VS-1726 |
Liver
|
PAXgene |
1
|
2 pieces; advanced portal cirrhosis and steatosis
|
Acceptable
|
|
GTEX-1C6WA
|
61-70
|
Male
|
GTEX-1C6WA-1226 |
Liver
|
PAXgene |
2
|
2 pieces; periportal fragmentation of cord cells greater than central
|
Acceptable
|
|
GTEX-1CAMQ
|
41-50
|
Male
|
GTEX-1CAMQ-1426 |
Liver
|
PAXgene |
0
|
2 pieces; marked congestion
|
Acceptable
|
|
GTEX-1CAV2
|
41-50
|
Female
|
GTEX-1CAV2-0926 |
Liver
|
PAXgene |
1
|
2 pieces; no fat or significant lesions
|
Acceptable
|
|
GTEX-1CB4F
|
61-70
|
Male
|
GTEX-1CB4F-1726 |
Liver
|
PAXgene |
1
|
2 pieces; congested
|
Acceptable
|
|
GTEX-1CB4G
|
51-60
|
Male
|
GTEX-1CB4G-1626 |
Liver
|
PAXgene |
2
|
2 pieces, moderate chronic passsive congestion
|
Acceptable
|
|
GTEX-1CB4H
|
61-70
|
Female
|
GTEX-1CB4H-1326 |
Liver
|
PAXgene |
1
|
2 pieces; mild mainly periportal macrosteatosis
|
Acceptable
|
|
GTEX-1CB4J
|
61-70
|
Male
|
GTEX-1CB4J-0726 |
Liver
|
PAXgene |
1
|
2 pieces, moderate chronic passive congestion
|
Acceptable
|
|
GTEX-1E1VI
|
51-60
|
Male
|
GTEX-1E1VI-1926 |
Liver
|
PAXgene |
1
|
2 pieces; diffuse macrovesicular and steatosis (80% fat)
|
Acceptable
|
|
GTEX-1E2YA
|
51-60
|
Male
|
GTEX-1E2YA-1226 |
Liver
|
PAXgene |
1
|
2 pieces, marked passive congestion, approaching hemorrhagic infarcts, rep delineated; macrovesicular steatosis involves ~20% of parenchyma
|
Acceptable
|
|
GTEX-1EH9U
|
61-70
|
Male
|
GTEX-1EH9U-1126 |
Liver
|
PAXgene |
1
|
2 pieces; 5% macrosteatosis
|
Acceptable
|
|
GTEX-1EKGG
|
61-70
|
Male
|
GTEX-1EKGG-1226 |
Liver
|
PAXgene |
1
|
2 pieces; congestion, mild steatosis
|
Acceptable
|
|
GTEX-1EMGI
|
61-70
|
Male
|
GTEX-1EMGI-1326 |
Liver
|
PAXgene |
1
|
2 pieces, 10-20% hilar fibrous connective elements, rep delineated
|
Acceptable
|
|
GTEX-1EN7A
|
41-50
|
Male
|
GTEX-1EN7A-2026 |
Liver
|
PAXgene |
1
|
2 pieces; severe centrilobular macrovesicular steatosis; 1 mm bile duct hamartoma (von Meyenberg complex) [labeled]
|
Acceptable
|
|
GTEX-1EU9M
|
61-70
|
Male
|
GTEX-1EU9M-0826 |
Liver
|
PAXgene |
1
|
2 pieces, patchy macrovesicular steatosis involves ~20% of parenchyma
|
Acceptable
|
|
GTEX-1EWIQ
|
61-70
|
Female
|
GTEX-1EWIQ-0726 |
Liver
|
PAXgene |
2
|
2 pieces; mild to moderate steatosis
|
Acceptable
|
|
GTEX-1EX96
|
51-60
|
Male
|
GTEX-1EX96-0326 |
Liver
|
PAXgene |
1
|
2 pieces, moderate fibrosis/cardiac cirrhosis pattern
|
Acceptable
|
|